Clinical Trials Logo

Clinical Trial Summary

Phase 3 study to evaluate the effiacay and safety of YYC506

Clinical Trial Description

Phase 3 study to evaluate the effiacay and safety of YYC506 in patients with complex dyslipidemia where LDL-C is properly controlled but TG and HDL-C levels are not regulated by Atorvastatin alone. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04858308
Study type Interventional
Source Yooyoung Pharmaceutical Co., Ltd.
Contact Seul Gi Ha, PM
Phone 82-2-6202-7105
Email [email protected]
Status Recruiting
Phase Phase 3
Start date January 29, 2021
Completion date January 31, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04125784 - Lipid Profile and Diabetes Mellitus in People With HIV
Completed NCT04052594 - A Study of LY3475766 in Healthy Participants Phase 1
Recruiting NCT04270084 - Metabolic Optimization Through Diet/Lifestyle Improvements For Youth N/A
Active, not recruiting NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Recruiting NCT04516291 - A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) Phase 2
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT04186780 - Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study N/A
Not yet recruiting NCT03674333 - Effect of Adding Folic Acid on Lipid Parameters in Population With Dyslipidemias N/A
Terminated NCT01697735 - The Therapeutic Effects of Statins and Berberine on the Hyperlipemia Phase 4
Completed NCT00362908 - Effects of Low and Moderate Fat Diets on Lipids, Inflammation and Vascular Reactivity in the Metabolic Syndrome N/A
Completed NCT00644709 - A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) Phase 4
Recruiting NCT03988101 - Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event Phase 4
Completed NCT01218204 - A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin Phase 2
Completed NCT04079530 - A Clinical Pharmacology Study of K-877 Controlled Release Tablet Phase 2
Recruiting NCT04634591 - The Bialystok Bariatric Surgery Study
Withdrawn NCT03047538 - Fixed Combination for Lipid and Blood Pressure Control Phase 4
Completed NCT04437459 - The Reproducibility and Clinical Utility of an Abbreviated Fat Tolerance Test N/A
Completed NCT03294044 - The Effectiveness of Smart Health Management Program for Patients With Chronic Illness N/A
Completed NCT03251690 - Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression N/A
Completed NCT04807959 - Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program